Skip to main content
Log in

A strategy for fusion expression and preparation of functional glucagon-like peptide-1 (GLP-1) analogue by introducing an enterokinase cleavage site

  • Original Research Paper
  • Published:
Biotechnology Letters Aims and scope Submit manuscript

Abstract

KGLP-1, a 31-amino acid glucagon-like peptide-1 (GLP-1) analogue, has a great therapeutic potential for anti-diabetes. In this work, a strategy for expression and purification of functional KGLP-1 peptide has been established. KGLP-1 cDNA was fused with glutathione S-transferase (GST), with an enterokinase cleavage site in the fusion junction. The recombinant fusion protein GST–KGLP-1 was affinity purified via the GST-tag, and then digested with enterokinase. The resulting GST part as well as the enzymes were eliminated by ultra-filtration followed by size exclusion chromatograph. The yield of purified KGLP-1 was approximately 12.1 mg/L, with purity of 96.18 %. The recombinant KGLP-1 was shown to have similar bioactivity as native GLP-1 when evaluated in a Chinese hamster ovary cell line expressing a GLP-1 receptor-egfp reporter gene.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Chen J, Bai G, Yang Y, Geng P, Cao Y, Zhu Y (2007) Identifying glucagon-like peptide-1 mimetics using a novel functional reporter gene high-throughput screening assay. Peptides 28:928–934

    Article  PubMed  Google Scholar 

  • Drucker DJ, Nauck MA (2006) The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368:1696–1705

    Article  CAS  PubMed  Google Scholar 

  • Edman P (1950) Method for determination of the amino acid sequence in peptides. Acta Chem Scand 4:283–293

    Article  CAS  Google Scholar 

  • Gao Z, Tang Y, Chen J, Bai R, Zhang Q, Hou Y, Lu Y, Bai G (2009) A novel DPP-IV-resistant analog of glucagon-like peptide-1 (GLP-1): KGLP-1 alone or in combination with long-acting PLGA microspheres. Peptides 30:1874–1881

    Article  CAS  PubMed  Google Scholar 

  • Haque TS, Lee VG, Riexinger D, Lei M, Malmstrom S, Xin L, Han S, Mapelli C, Cooper CB, Zhang G, Ewing WR, Krupinski J (2010) Identification of potent 11mer glucagon-like peptide-1 receptor agonist peptides with novel C-terminal amino acids: homohomophenylalanine analogs. Peptides 31:950–955

    Article  CAS  PubMed  Google Scholar 

  • Kim S-G, Min W-K, Rho Y-T, Seo J-H (2012) Electrostatic interaction-induced inclusion body formation of glucagon-like peptide-1 fused with ubiquitin and cationic tag. Protein Exp Purif 84:38–46

    Article  CAS  Google Scholar 

  • Li P, Li X, Saravanan R, Li CM, Leong SSJ (2012) Antimicrobial macromolecules: synthesis methods and future applications. RSC Adv 2:4031–4044

    Article  CAS  Google Scholar 

  • Madsbad S (2009) Exenatide and liraglutide: different approaches to develop GLP-1 receptor agonists (incretin mimetics)—preclinical and clinical results. Best Pract Res Clin Endocrinol Metab 23:463–477

    Article  CAS  PubMed  Google Scholar 

  • Neidigh JW, Fesinmeyer RM, Prickett KS, Andersen NH (2001) Exendin-4 and glucagon-like-peptide-1: NMR structural comparisons in the solution and micelle-associated states. Biochemistry 40:13188–13200

    Article  CAS  PubMed  Google Scholar 

  • Rees JS, Lilley KS (2011) Method for suppressing non-specific protein interactions observed with affinity resins. Methods 54:407–412

    Article  CAS  PubMed  Google Scholar 

  • Schägger H, Von Jagow G (1987) Tricine–sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 166:368–379

    Article  PubMed  Google Scholar 

  • Scheen A (2007) Glucagon-like peptide-1 (GLP-1), new target for the treatment of type 2 diabetes]. Revue médicale de Liège 62:217

    CAS  PubMed  Google Scholar 

  • Tay DKS, Rajagopalan G, Li X, Chen Y, Lua LH, Leong SSJ (2011) A new bioproduction route for a novel antimicrobial peptide. Biotechnol Bioeng 108:572–581

    Article  CAS  PubMed  Google Scholar 

  • Wu J, Ruiz-Rodríguez J, Comstock JM, Dong JZ, Bode JW (2011) Synthesis of human GLP-1 (7–36) by chemoselective α-ketoacid–hydroxylamine peptide ligation of unprotected fragments. Chem Sci 2:1976–1979

    Article  CAS  Google Scholar 

  • Zhao T, Lv J, Zhao J, Huang X, Xiao H (2011) Expression of human globular adiponectin-glucagon-like peptide-1 analog fusion protein and its assay of glucose-lowering effect in vivo. Int J Med Sci 8:203

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the National High Technology Research and Development Program of China (863 Program 2012AA021505) and the National Natural Science Foundation of China (21002052).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Fang Bai.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 3242 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, Y., Ren, L., Ge, L. et al. A strategy for fusion expression and preparation of functional glucagon-like peptide-1 (GLP-1) analogue by introducing an enterokinase cleavage site. Biotechnol Lett 36, 1675–1680 (2014). https://doi.org/10.1007/s10529-014-1526-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10529-014-1526-1

Keywords

Navigation